Focus Partners Wealth
IDXX icon

Focus Partners Wealth’s Idexx Laboratories IDXX Stock Holding History

Focus Partners Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6M Buy
61,904
+1,716
+3% +$963K 0.03% 405
2026
Q1 		$33.8M Sell
60,188
-1,201
-2% -$770K 0.04% 373
2025
Q4 		$41.4M Buy
61,389
+9,471
+18% +$6.45M 0.05% 330
2025
Q3 		$33.2M Buy
51,918
+724
+1% +$439K 0.05% 289
2025
Q2 		$27.5M Buy
51,194
+4,363
+9% +$2.09M 0.06% 290
2025
Q1 		$19.7M Buy
46,831
+4,255
+10% +$1.85M 0.05% 329
2024
Q4 		$17.6M Buy
42,576
+27,830
+189% +$12.2M 0.05% 346
2024
Q3 		$4.99M Sell
14,746
-17,813
-55% -$8.65M 0.02% 561
2024
Q2 		$15.9M Buy
32,559
+29,444
+945% +$14.8M 0.05% 278
2024
Q1 		$1.68M Buy
3,115
+1,605
+106% +$877K 0.01% 514
2023
Q4 		$838K Buy
+1,510
New +$709K 0.01% 482

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Focus Partners Wealth's IDXX Position: Q2 2026 in Review

Focus Partners Wealth increased its Idexx Laboratories (IDXX) stake by 2.9% in Q2 2026, buying an estimated $963K and bringing the position to 61,904 shares worth $32.6M. The position accounts for 0.03% of the portfolio, ranked #405.

Focus Partners Wealth first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $41.4M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Focus Partners Wealth held 61,904 shares of Idexx Laboratories worth $32.6M as of Q2 2026.
  • Focus Partners Wealth bought 1,716 Idexx Laboratories shares in Q2 2026, an estimated $963K.
  • Idexx Laboratories made up 0.03% of Focus Partners Wealth's portfolio in Q2 2026, its #405 holding.
  • Focus Partners Wealth first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Idexx Laboratories position peaked at $41.4M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.